Table 2 Secondary outcome measures
Number | Percent of responders | |
|---|---|---|
Patients with ≥70% reduction in headache day frequency | 29 | 70.7% |
Patients with ≤1 headache day/ month | 9 | 22% |
Patients with ≥50% reduction in intercritic cervicalgia | 31 | 94% a |
Mean | ||
Percentage of reduction in triptans consumption vs baseline | 81% b | |
Patient satisfaction mean on a numerical scale from 0 to 10 (min-max) | 8,6 (6.5–10) |